Target intelligence / Profile preview

Kinesin family member 25 (KIF25)

Target
KIF25
Molecular classification
Motor protein, Microtubule-dependent molecular motor, Cytoskeletal protein (Kinesin superfamily, specifically kinesin-14 family)
01

Overview

Kinesin family member 25 (KIF25) is a minus-end directed microtubule motor protein of the kinesin-14 subfamily, expressed ubiquitously in human tissues[1][3][4][5]. It operates as a tetramer and is localized to centrosomes throughout the cell cycle[7]. KIF25 acts as a negative regulator of centrosome separation, tethering duplicated centrosomes together during interphase and helping to maintain a centered nucleus, thereby ensuring proper spindle orientation at mitosis onset[1][4][7]. Loss of KIF25 results in premature centrosome separation, nuclear mispositioning, and defects in spindle orientation, which may impact accurate chromosome segregation[7]. KIF25 has also been implicated, more generally as a member of the kinesin family, in cancer progression and as a possible contributor to disease phenotypes related to cell division and centrosomal defects[2][4]. There are no reported drugs directly targeting KIF25, and its precise role in human diseases, as well as its potential as a clinical biomarker or safety liabilities, remain underexplored.

Other names
KNSL3Kinesin-like protein KIF25Kinesin-like protein 3kinesin-14
02

Biological functions

Microtubule-based movementNegative regulation of centrosome separation during interphaseMaintenance of nucleus centering for proper spindle orientation during mitosisChromosome segregationPotential negative regulation of autophagy (less certain)
03

Disease associations

Cancer (general evidence for kinesin superfamily proteins; no direct disease association for KIF25, but implicated in cell division and centrosomal processes)Thrombophlebitis migrans (reported association)Teebi hypertelorism syndrome 1 (reported association)

Beyond the preview

Go deeper on Kinesin family member 25 (KIF25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin family member 25 (KIF25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call